Heterogeneity and prognosis in dementia of the Alzheimer type.

R. Mayeux, Y. Stern, M. Sano
{"title":"Heterogeneity and prognosis in dementia of the Alzheimer type.","authors":"R. Mayeux, Y. Stern, M. Sano","doi":"10.7916/D8ZS4CZ8","DOIUrl":null,"url":null,"abstract":"The diagnosis of dementia of the Alzheimer type (DAT) depends on the clinician's ability to document intellectual impainnent in the patient and to exclude other causes of dementia. About 50% of all demented patients entering a hospital are ultimately found at postmortem examination to have Alzheimer's disease. However, using the most rigorous criteria the accuracy of correct clinical diagnosis at autopsy approaches only 80-90% and this excludes some unusual patients. Most investigators use the Diagnostic and Statistical Manual of Mental Disorder-third ed. (DSM-III) criteria for dementia, a rating of perfonnance in activities of daily living, and an assessment of personality and intellectual function for diagnosis. Two clinical rating scales: the Blessed Dementia Rating Scale (parts 1 and 2) and the Clinical Dementia Rating Scale, are used frequently and seem to identify patients with DAT with greater accuracy than other scales. Our assessment protocol for dementia includes a quantitative neurological examination because certain motor manifestations have been observed in DAT: myoclonus, rigidity, stooped posture, and bradykinesia. We found these clinical features to be useful in predicting the course in some patients. Our data indicate clinical heterogeneity in DAT and may suggest the presence of unique subgroups.","PeriodicalId":77682,"journal":{"name":"Bulletin of clinical neurosciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of clinical neurosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7916/D8ZS4CZ8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

The diagnosis of dementia of the Alzheimer type (DAT) depends on the clinician's ability to document intellectual impainnent in the patient and to exclude other causes of dementia. About 50% of all demented patients entering a hospital are ultimately found at postmortem examination to have Alzheimer's disease. However, using the most rigorous criteria the accuracy of correct clinical diagnosis at autopsy approaches only 80-90% and this excludes some unusual patients. Most investigators use the Diagnostic and Statistical Manual of Mental Disorder-third ed. (DSM-III) criteria for dementia, a rating of perfonnance in activities of daily living, and an assessment of personality and intellectual function for diagnosis. Two clinical rating scales: the Blessed Dementia Rating Scale (parts 1 and 2) and the Clinical Dementia Rating Scale, are used frequently and seem to identify patients with DAT with greater accuracy than other scales. Our assessment protocol for dementia includes a quantitative neurological examination because certain motor manifestations have been observed in DAT: myoclonus, rigidity, stooped posture, and bradykinesia. We found these clinical features to be useful in predicting the course in some patients. Our data indicate clinical heterogeneity in DAT and may suggest the presence of unique subgroups.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿尔茨海默型痴呆的异质性和预后。
阿尔茨海默型痴呆(DAT)的诊断取决于临床医生记录患者智力损伤的能力,并排除痴呆的其他原因。入院的所有痴呆患者中,约有50%最终在尸检时被发现患有阿尔茨海默病。然而,使用最严格的标准,正确的临床诊断的准确性在尸检接近只有80-90%,这排除了一些不寻常的病人。大多数研究者使用第三版《精神障碍诊断与统计手册》(DSM-III)的痴呆标准,对日常生活活动的表现进行评估,并对人格和智力功能进行评估。两种临床评定量表:祝福痴呆评定量表(第1部分和第2部分)和临床痴呆评定量表被频繁使用,似乎比其他量表更准确地识别出患有DAT的患者。我们对痴呆的评估方案包括定量的神经学检查,因为在DAT中观察到某些运动表现:肌阵挛、僵硬、弯腰和运动迟缓。我们发现这些临床特征对预测某些患者的病程是有用的。我们的数据显示了DAT的临床异质性,可能表明存在独特的亚群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Update on cholinergic enhancement therapy for Alzheimer disease. Language disorders: clinical classification and neurovascular substrate. The neuropathology of Alzheimer disease. Proceedings of a workshop presented by the John Douglas French Foundation for Alzheimer's Disease. November 6-7, 1986. Abstracts. Some personal thoughts on the nature and management of recurrent headaches. Recurrent meningitis due to nonsteroidal anti-inflammatory drugs.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1